XML 60 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
units
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
units
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Disaggregation of Revenue [Line Items]          
Emerging Markets total countries | units 20   20    
Net sales $ 2,932 $ 2,659 $ 8,761 $ 7,204  
Contract with Customer, Liability [Abstract]          
Contract with Customer, Liability 455   455   $ 395
Change in Contract with Customer, Liability [Abstract]          
Contract with Customer, Liability, Revenue Recognized 39   113    
United States          
Disaggregation of Revenue [Line Items]          
Net sales 1,726 1,560 5,112 4,167  
International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 1,206 1,098 3,649 3,037  
Emerging Markets [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 354 291 1,030 832  
Global Endoscopy (Endo) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 533 475 1,583 1,265  
Global Endoscopy (Endo) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 306 270 902 715  
Global Endoscopy (Endo) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 227 205 681 550  
Global Urology (Uro) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 384 350 1,142 910  
Global Urology (Uro) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 275 251 817 650  
Global Urology (Uro) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 109 99 325 260  
Global CRM Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 512 465 1,505 1,253  
Global CRM Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 312 275 903 738  
Global CRM Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 199 190 603 515  
Global Electrophysiology (EP) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 86 76 265 202  
Global Electrophysiology (EP) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 32 33 96 86  
Global Electrophysiology (EP) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 55 43 169 116  
Global Neuromodulation (NM) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 221 216 666 529  
Global Neuromodulation (NM) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 175 176 520 426  
Global Neuromodulation (NM) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 46 41 145 103  
Global Interventional Cardiology (IC) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 744 586 2,230 1,714  
Global Interventional Cardiology (IC) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 376 255 1,117 741  
Global Interventional Cardiology (IC) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 368 331 1,113 973  
Global Peripheral Interventions (PI) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 452 416 1,358 1,148  
Global Peripheral Interventions (PI) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 250 236 748 649  
Global Peripheral Interventions (PI) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 202 179 609 499  
Specialty Pharmaceuticals [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 0 74 13 183  
Specialty Pharmaceuticals [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 0 65 10 162  
Specialty Pharmaceuticals [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 0 10 4 21  
BSX Reportable Segments [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 2,932 2,584 8,748 7,021  
BSX Reportable Segments [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 1,726 1,496 5,103 4,005  
BSX Reportable Segments [Member] | EMEA [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 590 540 1,855 1,507  
BSX Reportable Segments [Member] | APAC [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 517 472 1,511 1,292  
BSX Reportable Segments [Member] | Latin America and Canada [Member]          
Disaggregation of Revenue [Line Items]          
Net sales $ 99 $ 77 $ 279 $ 217